1 In an effort to elucidate the nature ofthe inhibitory effects ofp-bromophenacyl bromide (pBPB) on neutrophil stimulation, we have examined its effects on several stages of stimulus-response coupling. 2 Pretreatment of rat neutrophils with pBPB resulted in a dose-and time-dependent irreversible inhibition of both N-formylmethionyl-leucylphenylalanine (f Met-Leu-Phe)-induced lysosomal enzyme release and change in transmembrane potential. 3 Inhibition of the biological responses to the chemotactic peptide fMet-Leu-Phe was not due to receptor inactivation since fMet-Leu-[3H]-Phe binding to the formyl peptide receptor was not significantly altered by pBPB pretreatment. 4 Inhibition by pBPB of phorbol myristate acetate (PMA)-induced changes in transmembrane potential and the generation of superoxide (02) was also observed. 5 pBPB treatment appeared to inhibit activation of the NADPH oxidase without a direct effect on the oxidase itself. 6 This inhibitory effect was not accompanied by cell death or decrease in cellular titratable sulphydryl groups (at least at doses <20 pM).
Introduction
Stimulation of polymorphonuclear leukocytes by chemotactic or phagocytic stimuli results in a series of reactions that eventually terminate in chemotaxis and/ or phagocytosis with associated generation of oxygen radicals and release ofgranule bound enzymes such as lysozyme and P-glucuronidase (Weissman et al., 1980) . Additionally, oxidation products of arachidonic acid via the cyclo-oxygenase, and lipoxygenase pathways are formed which can in turn modulate the cellular responses (Goetzl, 1980) . The mechanisms involved in the process of stimulus-secretion coupling have been partially elucidated (Weissman et al., 1980) . Among these, depolarization of the transmembrane potential as 'Author for correspondence.
assessed by an increase in the fluorescence intensity of the optical probe of membrane potential 3-3'-dipropylthiadicarbocyanine iodide, [diS-C3-(5)], is detectable within seconds of exposure of neutrophils to different stimuli (Sklar et al., 1980) . This event can be correlated to the functional response phase of neutrophil stimulation (Duque et al, 1983) . Moreover, using protease inhibitors, such as L-l-tosylamide-2-phenylethyl chloromethyl ketone (TPCK), we have recently shown that a chymotrypsin-like activity is required for cell stimulation including transmembrane potential changes. This inhibition can be overcome by exposure of TPCK-treated neutrophils to the calcium ionophore A23187 in the presenceof > 1.5 mMCa suggesting that the TPCK inhibitable activity precedes a 2+ requiring step (Duque et al., 1983) . This ) The Macmillan Press Ltd 1986 esterase activity may be related to the Ca2" dependent (Derksen & Cohen, 1975 ) activation of a cell bound phospholipase A2 (phosphatide 2-acyl-hydrolase, EC 3.1.1.4), which has been identified in plasma membranes of neutrophils (Victor et al., 1981) . The subsequent release of unesterified arachidonic acid from cellular phospholipids by the activated phospholipase A2 is considered to be an initial requirement for the synthesis and secretion of prostaglandins and other arachidonic acid metabolites (Kuehl & Egar, 1980) . Arachidonic acid can also be released by the combined action of phospholipase C and diacylglycerol lipase (Bell et al., 1979) . Treatment of neutrophils with p-bromophenacyl bromide (pBPB), an 'active site directed' inhibitor of phospholipase A2 by alkylation of a histidine residue, has been reported to inhibit superoxide generation and enzyme release (Smolen & Weissman, 1980) . Although there is currently no evidence to indicate that the neutrophil enzyme contains a histidine residue at its active site, a likely target for this inhibition is the membrane bound phospholipase A2 (Bormann et al., 1984) . Accordingly, we have investigated the effects of p-bromophenacyl bromide on several physiological responses associated with stimulus-response coupling in rat neutrophils, and attempted to demonstrate the extent of specificity of this reagent on the observed inhibition.
Methods

Neutrophils
Healthy, adult, male, Long-Evans rats (Charles River Laboratory) (250 to 350 g) were used. Neutrophils were elicited from the peritoneal cavity by use of a solution of 1% oyster glycogen (Becker, 1972) . Cell suspensions were >95% neutrophils as assessed by toluidine blue staining. All assays described below were performed at least in duplicate, although most were done in triplicate. Data Lysozyme, P-glucuronidase and lactic dehydrogenase activities were measured as described previously (Becker et al., 1977) . Results were expressed as percentage ofenzyme activity present in lysates of cells treated with 0.1% Triton X-100.
Preparation of subcellular particles and NADPH oxidase assay
In selected experiments the NADPH oxidase activity was determined in the 27,000 g particle fraction of sonicated neutrophils as previously described (McPhail et al., 1976) . Briefly, rat neutrophils were divided into two aliquots. One was treated with 1O gM pBPB from (10-2 M stock solutions made in absolute ethanol) for 10 min at room temperature, washed, and followed by stimulation with phorbol myristate acetate (PMA, 200mgml-') for 10min at 37°C. A second group was treated with PMA alone. Following sonication and low speed centrifugation to remove intact cells and nuclei, the 27,000 g pellet was obtained and designated as subcellular particles. Subcellular particles from PMA-treated cells were also prepared and treated with pBPB (1I0 1M) for 10 min at room temperature before assay for NADPH oxidase. The ability of 50 Ml of each preparation to produce superoxide dismutase-inhibitable O2 after incubation for 15 min at room temperature in the presence of NADPH was determined. Particles from non-PMAstimulated cells routinely produced less than 2 nmol 0°mg-' protein.
Membrane potential changes
Membrane potential changes were measured as previously described (Duque et al., 1983) . Neutrophils (2 x 106) were equilibrated for 3-4min with 2 x 10-6 M diS-C3-(5), in a Varian SF-330 spectrofluorometer at 37°C, with constant stirring. The excitation wavelength was 622 nm and the emission wavelength, 665 nm, with bandwidths of 10 nm. Final concentrations of dimethyl sulphoxide (Me2SO) and ethanol did not exceed 0. 1%. Stimuli were added after equilibration and the fluorescence monitored for 6-7 min using a chart recorder. Data are expressed as the maximal change in fluorescence (AF). Exposure of cell suspensions to the dye never exceeded 10 min. The resting membrane potential was calculated by the 'null point' method (Laris et al., 1976) , based on the external potassium concentration [K+] at which there is no change in fluorescence intensity upon the addition of valinomycin (2 x 10-6M) in the presence and absence of pBPB (5 gM for 10 min at 37'C).
diS-C3-(5) has been reported to exert toxic effects on Ehrlich ascites tumour cells by rapidly depleting them of ATP in glucose-free medium (Smith et al., 1981) . Accordingly, we measured ATP in suspensions of neutrophils as assessed by the chemiluminescent response in the luciferrin-luciferase system (Stanley & Williams, 1969 
Sulphydryl group titration
Titration of free sulphydryl groups was accomplished using 5,5'-dithiobis(2-nitrobenzoic acid) according to Deakin et al. (1963) . Cells with or without pBPB pretreatment were reacted with this reagent (100 gM)
for 30 min at room temperature. The absorbence at 412 nm was determined and used to quantitate the amount of free SH groups (Deakin et al., 1963) .
Analysis offMet-Leu-[3H]-Phe binding
The following protocol was used to assess the effect of pBPB on the time course of N-formylmethionylleucyl-[3H]-phenylalanine (fMet-Leu-[3H]-Phe) binding. Neutrophils (2.0 x 107 cellsml') were preincubated at 37TC for 15 min in buffer before the start of each experiment. The cells were divided into two tubes, one of which was treated with pBPB (10 gM final concentration): 350 pI aliquots were then removed from each tube at various times, placed into 12 x 75mm glass test tubes, diluted with 4 ml of ice cold buffer (no dextrose) and centrifuged at 900 g for 8 min. The supernatants were discarded, and the cell pellets were resuspended in 350 p1 of buffer, to which 10 mM 2-deoxy-D-glucose and 109 mM NaN3 had been added to minimize receptor internalization during the binding studies (Marasco et al., 1983 (Marasco et al., 1983) . Only specific binding is described in this paper. The cells were harvested by a glass fiber vacuum filtration method and analyzed for cell bound radioactivity. All data points represent the means of triplicate determinations.
Phospholipase A2 assay Phospholipase A2 assay was performed according to Franson et al. (1974) with slight modification. L-aC-1-Palmitoyl-2-[palmitoyl-9, 1 0-3H]-phosphatidylcholine (30-60 Ci mmol-) was used as substrate. Rat peritoneal neutrophils (108) were treated with 10-5 M pBPB at 37°C for 15 min. Control cells were similarly incubated in the absence of pBPB. Cells were then washed once with 0.34M sucrose in 10mM Tris HCI pH 7.5, and sonicated on ice at 30 W in three bursts of 10 s each. Cell breakage was better than 90% as monitored by the microscope. After centrifugation at 600 g for 20 min, 4°C, the supernatant was further spun at 27,000 g for 20 min at 4°C. The supernatant and pellet were collected and used for assay as the soluble and particulate or membranous fractions (subcellular particles) respectively. Fractions of these samples (equivalent to 2 x 106 cells) were incubated with 0.2 pCi substrate diluted with 5 nmol of cold phosphatidylcholine in a final volume of 0.5 ml. The buffer contained 10 mM CaC12 and 100 nM Tris HCI pH 8.0. After 60 min at 37°C, the entire mixture was extracted with CHCI3-CH30H containing 0.5 mg palmitic acid as previously described (Blight & Dyer, 1959 [palmitoyl -9,10 -3H] -phosphatidylcholine, were purchased from New England Nuclear (Boston, Mass.). All other chemicals were of analytical reagent grade.
Buffer
Unless otherwise specified, the buffer used for all experiments, consisted of (mM): NaCl 140, KCI 5.4, CaCl2 1.8, MgSO4 0.8, Na2HPO4 0.8, KH2PO4 0.8, Tris 22.5, glucose 5, pH 7.4. In addition, enzyme release assays were performed in the presence of bovine serum albumin 1 mg ml -'.
Results
Effects on lysosomal degranulation
The oligopeptide f Met-Leu-Phe stimulates rat neutrophils to release lysosomal enzymes in a dose-dependent manner. Figures la and b show the dose-dependent release of P glucuronidase and lysozyme respectively. Preincubation (10min at 37C) of these cells with pBPB before stimulation inhibited this degranulation in a dose-dependent manner, such that at >10 tM, there was a virtually total inhibition of enzyme release. This inhibition was irreversible as determined by its persistence after removal of unreacted pBPB by exhaustive washing of the cells prior to stimulation (data not shown). This inhibition also showed virtually identical kinetics as the inhibition of transmembrane potential changes (shown in Figure 4 ). pBPB had no effects on the enzyme assays themselves. These doses of pBPB also had no effect on viability as determined by the lack of LDH activity (above baseline control levels) in the cell supernate.
Effects on superoxide production
The inhibitory effect of pBPB was also observed in fMet-Leu-Phe stimulation of 0°production. Although this peptide is a weak or suboptimal stimulator of 0°production in rat neutrophils, a clear inhibitory effect by 5gM pBPB was observed. Thus, 10-6M fMet-Leu-Phe caused the production of 5.6 ± 0.27 (s.e., n = 3) mmoles by 6 x 106 cellsml-' in 15min, which reduced to 2.3 ± 0.03 (n = 5) in the presence of 5gM pBPB.
Since rat neutrophils produced relatively small amounts of 02 upon fMet-Leu-Phe stimulation, we have confirmed this inhibitory effect using PMA, which is a more potent stimulant of 0-2 release. Figure 2 shows a dose-dependent inhibition of 0-2 production by pBPB. In this case, however, I AM was effective in decreasing 02 production by > 50% at all doses of PMA examined, while 5 pM totally abolished 0-2 production. This inhibition was also irreversible and time-dependent (data not shown).
These data confirm a previous study with a higher dose of pBPB in human neutrophils (Smolen & Weissman, 1980) . This inhibition was not due to direct inhibition of the NADPH oxidase itself as shown by the data in Table 1 . These studies revealed that treatment ofintact cells with 10 JIM pBPB inhibited the (Sklar et al., 1980; Whitin et al., 1980; Duque et al., 1983) . Rat neutrophils showed similar dose-dependent responses (Figures 3a and b) . These changes as probed using the fluorescent dye diS-C3-(5) (Laris et al., 1976 , Whiting et al., 1980 , were also inhibited by pBPB in a dosedependent manner, with complete inhibition achieved -;9 -A--~-6 at doses> 10 ;M (Figures 3a and b peptide receptor is dependent on intact free sulphydryl sulphydryls in platelets (Hoffmann et al., 1982) . Direct groups (24,26), this lack of inhibition by pBPB also measurement of the number of titratable sulphydryl indicated its lack of effect on accessible free sulgroups in whole neutrophils revealed that pBPB at phydryls. This point is an important one since pBPB at doses of <20 gM had no significant effect on this high doses (> 50 gM) is known to have non-specific parameter (Table 3) . Thus, pBPB inhibition cannot be effects, such as reducing the number of titratable explained by such non-specific effects.
Effects on phospholipase A2 activity
The above studies revealed that pBPB inhibited an early step in the sequence of events leading to neutro- Assay of whole cell homogenates (from resting and fMet-Leu-Phe-stimulated cells) revealed <20% inhibition of total phospholipase A2 activity by pBPB. However, when only the subcellular particulate or membranous fraction (27,000 g pellet) was assayed for phospholipase A2 pBPB inhibition was more dramatic (Table 4) , and of a similar order of magnitude as its inhibition of stimulated cellular functional responses. The data revealed complete inhibition by pBPB of fMet-Leu-Phe stimulatable activity in these subcellular particles without affecting the resting enzymatic activity (Table 4) . Thus, although pBPB Table 3 Effect of p-bromophenacyl bromide (pBPB) on cellular titratable sulphydryl groupsa failed to inhibit significantly (at least to the extent ofits inhibition of stimulated cellular functional responses) whole cell phospholipase A2 activity, it was very effective in inhibition of the f Met-Leu-Phe stimulatable activity residing in the subcellular pariculate fraction containing plasma membrane and other membranous fragments. The ability of fMet-Leu-Phe to stimulate phospholipase A2 activity in the subcellular particles is in contrast to the lack of such stimulation in the 100,000 g pellet as reported by Lanni & Backer (1983) . This difference may be due to the use of H2SO4 to 'extract' the enzyme before assay, in their study. A subsequent paper from the same laboratory however, supported our observation of an inducible phospholipase A2 activity in rabbit neutrophil plasma membrane (Bormann et al., 1984) . Their more recent paper also demonstrates the ineffectiveness of pBPB in inhibiting phospholipase A2 added to whole, intact cells (<20%), although this reagent is highly effective in inhibition of enzyme activity in cell sonicates or acid extracts (Lanni & Becker, 1985) . In that study however, the effect of f Met-Leu-Phe stimulation is not examined. (Smolen & Weissman, 1980) The inhibitory effects ofpBPB on membrane potential changes suggest a requirement for a pBPB-sensitive activity in the production of a state of altered permeability to ions following stimulation. That a phospholipase A2-like activity could also be involved is suggested by recent reports (Yorio et al., 1983) showing that phospholipid metabolites can contribute to alteration of membrane permeability in frog skin epithelium and that the increase in sodium transport observed is mediated through the release of arachidonic acid and the synthesis of prostaglandins.
Furthermore, a Ca2+-dependent, neutral pH active phospholipase A2 has been described in rabbit alveolar macrophages (Franson et al., 1973) and granulocytes (Franson et al., 1974) .
Recent studies by another laboratory have also reported on a stimulatable phospholipase A2 activity in rabbit neutrophil plasma membranes (Bormann et al., 1984) . The same laboratory also more recently noted, that despite the ability of pBPB to inhibit phospholipase A2 activity in cell sonicates and acidextracts, it is only minimally inhibitory (<20%) if introduced to intact cells (Lanni & Becker, 1985) . Our data are consistent with these findings, and we have extended them further by reporting inhibition of only the fMet;Leu-Phe stimulatable enzyme activity.
Additional evidence for the role of a cell bound phospholipase A2 in the release of arachidonate from human neutrophil phospholipids has been presented by Walsh et al. (1980; 1981) . The ability of some of these arachidonate metabolites to initiate and/or modulate ion fluxes would then have an impact on transmembrane potential changes.
Although localization and identification of the target site(s) for pBPB remain uncertain, our data demonstrate that, with the dose and conditions used, sulphydryl groups are not affected. This conclusion is based partially and indirectly on the lack of inhibition of f Met-Leu-Phe binding, since it is known that intact sulphydryl groups are essential to maintain the integrity of the formyl peptide receptor (Schiffmann et al., 1980; Niedel, 1981) . Furthermore, and more directly we could not demonstrate significant reduction of cellular titratable sulphydryl groups at concentrations of pBPB below 20 tiM. Additionally, if pBPB were to alter non-specifically free sulphydryl groups, one would expect inhibition of NADPH oxidase activity (McPhail et al., 1976) . However, this was not observed and instead pBPB was found to inhibit a regulatory step other than the structural proteins involved in the expression of NADPH oxidase activity. The data would suggest interference with activation steps required for the expression or assembly ofNADPH oxidase activity and not on the oxidase itself. In this study pBPB was used at considerably lower concentrations (< 10 ptM) than was the case in studies by other investigators who have shown nonspecific inhibitor effects on other enzymes (Hofmann et al., 1982; Kyger & Franson, 1984) . In one of these studies (Hofmann et al., 1982) , 30LM pBPB caused a 63% inhibition of phospholipase C activity after 15 min incubation. Diglyceride lipase was inhibited by only 56% after 30 min incubation with 500 ZtM pBPB.
These concentratons are from 3 -50 times the maximal dose used in this study, which could account for the differences between that study and our data. Another study purporting to show inhibition of acid proteases by pBPB (Ackerman et al., 1983) to explain its neutrophil inhibitory effects, failed to realize that pBPB does not inhibit acid proteases at pH > 5.0 (Gross & Morell, 1966) . In view of these considerations, the effects of pBPB exposure described in this paper are likely to be due to inhibition of one or more early regulatory activities, of which a critical membranous fraction of stimulatable cellular phospholipase A2 appears to be a candidate. However, other sites of inhibition, as yet unidentified cannot be ruled out at this time especially in view of the hydrophobic nature of pBPB and its ability to partition at high local concentrations in membranes. A possible and as yet unexplored target is the Ca2+-dependent intracellular signalling system based on the metabolism of inositol phospholipids (Berridge, 1984) .
We conclude: (a) that pBPB at concentrations of <1O JM inhibit neutrophil functional responses to several stimuli; (b) the inhibitable step(s) involved in the stimulus-response process precede the activation or assembly of the NADPH oxidase required for the generation ofO2 and (c) the inhibitory effects include 'early' events such as the ligand-induced change in transmembrane potential. Finally, the inhibition of a critical membranous fraction of cell bound phospholipase A2 by pBPB would suggest that this enzyme may be crucial to subsequent cell activation. The inability to inhibit unstimulated (or 'resting') phospholipase A2 activity would suggest that pBPB may inhibit the regulatory step(s) necessary for activation of this membrane bound phospholipase A2, rather than alkylating the activatable or activated enzyme itself. This possibility is also suggested by the ability of pBPB to inhibit the stimulatable enzyme activity in the presence of physiological concentrations of Ca2+, which is known to make the enzyme less susceptible to alkylation by pBPB (Roberts et al., 1977) . There is no conclusive evidence at this time that the neutrophil phospholipase A2 contains a histidine at its active site, although its susceptibility to pBPB inhibition (Lanni & Lecker, 1985) makes it a likely possibility. Finally, the available data would not allow any conclusions to be reached concerning the commonness of the mechanism by which fMet-Leu-Phe and PMA stimulate neutrophils.
